GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

• Status: Completed
• Trial end date: 2020-02-28
• Target enrollment: 0
• Participant gender: All

Summary

This study will investigate if the effect of DPP-4 inhibitors is mediated in part by Glucose-dependent insulinotropic polypeptide.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Gentofte, Copenhagen
• Treatments: Dipeptidyl-Peptidase IV Inhibitors; Gastric Inhibitory Polypeptide; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• type 2 diabetes, treatment: lifestyle changes or metformin

• HbA1c < 75 mmol/mol

Exclusion Criteria:

• diagnosed liver disease

• eGFR < 60 ml/min/1,73m2

• NYHA III or IV

• anemia.